Molecular Pathways: Translational and Therapeutic Implications of the Notch Signaling Pathway in Cancer
Year: 2015
Type: review
Abstract: Over 100 years have passed since the first observation of the notched wing phenotype in Drosophila melanogaster, and significant progress has been made to characterize the role of the Notch receptor, its ligands, downstream targets, and cross-talk with other signaling pathways. The canonical Notch pathway with four Notch receptors (Notch1-4) and five ligands (DLL1, 3-4, Jagged 1-2) is an evolutionarily conserved cell signaling pathway that plays critical roles in cell-fate determination, differentiation, development, tissue patterning, cell proliferation, and death. In cancer, these roles have a critical impact on tumor behavior and response to therapy. Because the role of Notch remains tissue and context dependent, alterations within this pathway may lead to tumor suppressive or oncogenic phenotypes. Although no FDA-approved therapies currently exist for the Notch pathway, multiple therapeutics (e.g., demcizumab, tarextumab, GSI MK-0752, R04929097, and PF63084014) have been developed to target different aspects of this pathway for both hematologic and solid malignancies. Understanding the context-specific effects of the Notch pathway will be important for individualized therapies targeting this pathway.
Source: Clinical Cancer Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: G1425849753, MD Anderson Gynecologic SPORE for Uterine Cancers, Texas Center for Cancer Nanomedicine, Novel extra cellular RNA-based combinatorial RNA inhibition therapy, Platelets promote growth of ovarian cancer, Ovarian Cancer: Mechanisms of Neuroendocrine Regulation, UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2), Novel extra cellular RNA-based combinatorial RNA inhibition therapy, UPR/MDACC: Partnership for Excellence in Cancer Research (2 of 2), G6910379328, NIHR Senior Investigator Award, The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer, Cancer Center Support Grant, Training of Academic Gynecologic Oncologists
OpenAlex ID: W2047074552
